First in Class: Emerging Therapies for MGD-Related DED

Kelly K. Nichols, OD, MPH, PhD, FAAO, and Walter O. Whitley, OD, MBA, FAAO, discuss how meibomian gland dysfunction interacts with dry eye disease (DED) and summarize the latest clinical and real-world data on new and emerging treatments.  This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.